Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1959 Sep;14(3):355–357. doi: 10.1111/j.1476-5381.1959.tb00256.x

Ouabain-induced ventricular tachycardia and its effect on the performance and metabolism of the dog heart

G Fawaz, B Tutunji
PMCID: PMC1481746  PMID: 13821777

Abstract

At constant pressure work there was an increase in the oxygen consumption of the dog heartlung preparation after tachycardia due to auricular stimulation and a far greater increase in consumption after ouabain-induced ventricular tachycardia, as compared with control hearts beating at their own sinus rhythm. In neither condition was the increase in coronary flow greater than the spontaneous increase in the controls. It is suggested that an increase in oxygen demand, under certain circumstances, may be met primarily by an increased desaturation of coronary blood. “Therapeutic” doses of ouabain did not improve the mechanical efficiency of the preparation. “Toxic” doses of ouabain which gave rise to ventricular tachycardia did not decrease the phosphocreatine or labile nucleotide phosphorus content of the heart provided there was no hypoxia of the heart muscle.

Full text

PDF
356

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERGLUND E., BORST H. G., DUFF F., SCHREINER G. L. Effect of heart rate on cardiac work, myocardial oxygen consumption and coronary blood flow in the dog. Acta Physiol Scand. 1958 Feb 4;42(2):185–198. doi: 10.1111/j.1748-1716.1958.tb01551.x. [DOI] [PubMed] [Google Scholar]
  2. FAWAZ G., HAWA E. S. Phosphocreatine content of mammalian cardiac muscle. Proc Soc Exp Biol Med. 1953 Nov;84(2):277–280. doi: 10.3181/00379727-84-20616. [DOI] [PubMed] [Google Scholar]
  3. FAWAZ G., HAWA E. S., TUTUNJI B. The effect of dinitrophenol, hypoxaemia and ischaemia on the phosphorus compounds of the dog heart. Br J Pharmacol Chemother. 1957 Sep;12(3):270–272. doi: 10.1111/j.1476-5381.1957.tb00133.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FAWAZ G., TUTUNJI B. The mechanism of dinitrophenol heart failure. Br J Pharmacol Chemother. 1957 Sep;12(3):273–278. doi: 10.1111/j.1476-5381.1957.tb00134.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LAURENT D., BOLENE-WILLIAMS C., WILLIAMS F. L., KATZ L. N. Effects of heart rate on coronary flow and cardiac oxygen consumption. Am J Physiol. 1956 May;185(2):355–364. doi: 10.1152/ajplegacy.1956.185.2.355. [DOI] [PubMed] [Google Scholar]
  6. Starling E. H., Visscher M. B. The regulation of the energy output of the heart. J Physiol. 1927 Jan 12;62(3):243–261. doi: 10.1113/jphysiol.1927.sp002355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. WOLLENBERGER A. Metabolic action of the cardiac glycosides. II. Effect of ouabain and digoxin on the energy-rich phosphate content of the heart. J Pharmacol Exp Ther. 1951 Oct;103(2):123–135. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES